XML 66 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]                  
Revenue $ 2,400,311     $ 2,550,046     $ 8,919,312 $ 7,501,535  
Gross Profit 1,401,991     1,281,041     3,908,608 3,505,743  
Segment Assets 4,689,261     5,514,101     4,689,261 5,514,101 $ 5,766,164
Segment Profit/Loss (528,742) $ (1,112,261) $ (965,836) (1,301,748) $ (2,578,276) $ (651,519) (2,606,839) (4,531,543)  
Cost of Sales             5,010,704 3,995,792  
Trxade, Inc.[Member]                  
Segment Reporting Information [Line Items]                  
Revenue             4,001,670 3,653,269  
Gross Profit             4,001,670 3,652,015  
Segment Assets 1,853,474     1,487,657     1,853,474 1,487,657  
Segment Profit/Loss             1,320,138 1,511,809  
Cost of Sales             1,254  
Community Specialty Pharmacy, LLC [Member]                  
Segment Reporting Information [Line Items]                  
Revenue             905,083 1,287,296  
Gross Profit             (114,387) 123,470  
Segment Assets 236,827     (404,174)     236,827 (404,174)  
Segment Profit/Loss             (363,212) (89,025)  
Cost of Sales             1,019,470 1,163,826  
Integra Pharma, LLC [Member]                  
Segment Reporting Information [Line Items]                  
Revenue             3,949,772 2,511,270  
Gross Profit             (41,462) (319,104)  
Segment Assets 454,783     563,396     454,783 563,396  
Segment Profit/Loss             (493,203) (2,500,032)  
Cost of Sales             3,991,234 2,830,374  
Other Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenue             62,787 49,700  
Gross Profit             62,787 49,362  
Segment Assets $ 2,111,177     $ 3,867,221     2,111,177 3,867,221  
Segment Profit/Loss             (3,070,562) (3,454,295)  
Cost of Sales             $ 338